Welcome to Medilinks
Medilinks Inc is a facilitator of specialized Genomic and Genetic testing’s which help and guide
Physicians during patients treatment. Medilinks Inc founded in 2007.
Medilinks Inc is a facilitator of specialized Genomic and Genetic testing’s which help and guide
Physicians during patients treatment. Medilinks Inc founded in 2007.
The only genomic test proven to predict a patient’s individual benefit from chemotherapy. For patients with early-stage, ER-positive, HER2-negative, node negative, and node-positive (1-3) breast cancer, the Oncotype DX Breast Recurrence Score quantifies the risk of distant recurrence and the likelihood of chemotherapy benefit.